-->

Dr. Vince Clinical Research Announces Expansion of Overland Park Campus

Dr. Vince Clinical Research announced the constructing a new 5,000-square-foot administration building in its Overland Park campus. Photo credit: Dr. Vince Clinical Research.

Posted January 14, 2025

Dr. Vince Clinical Research announced it will expand its Overland Park research campus with the addition of a new administration building.

The new 5,000-square-foot administration building will support finance, human resources and volunteer recruitment departments, according to a Tuesday release.

“We are proud to commence construction on yet another building on our research campus,” CEO and chief medical officer at Dr. Vince Clinical Research, Dr. Brad Vince, said in the release. “Our original goal was to create a world-class contract research organization. The new administration building will help us achieve this goal by further facilitating our day-to-day operations and fostering collaboration and innovation amongst our team.”

The new building will mirror the existing headquarters, providing architectural and design continuity. JE Dunn Construction is the general contractor for the project and is expected to complete construction in December. 

Founded in 2021, DVCR operates a 90-bed clinical pharmacology unit outfitted with a clinical laboratory, a surgical suite and a cGMP-compliant pharmacy. In November, the organization announced the addition of an in-house laboratory to streamline new studies. The laboratory aids the DVCR’s clinical pharmacology unit by enabling in-house safety laboratory testing.

The organization currently has well over 175 employees across the United States, Canada, Europe and the United Kingdom.